Edward R. Garrett

Edward R. Garrett's AcademicInfluence.com Rankings

Edward R. Garrett

Philosophy

#5803

World Rank

#8706

Historical Rank

Logic

#3019

World Rank

#4111

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Edward R. Garrett Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Edward R. Garrett's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

[Clinical pharmacokinetics]. (1976) (716)
Physicochemical Properties, Solubility, and Protein Binding of Δ9 -Tetrahydrocannabinol (1974) (184)
Solvolysis of adenine nucleosides. I. Effects of sugars and adenine substituents on acid solvolyses. (1972) (119)
Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite. (1974) (102)
Evaluation, control, and prediction of drug diffusion through polymeric membranes. II. Diffusion of aminophenones through silastic membranes: a test of the pH-partition hypothesis. (1968) (89)
The Kinetics of Solvolysis of Acyl Esters of Salicyclic Acid (1957) (78)
Evaluation, control, and prediction of drug diffusion through polymeric membranes. I. Methods and reproducibility of steady-state diffusion studies. (1968) (77)
Pharmacokinetics of trichloroethanol and metabolites and interconversions among variously referenced pharmacokinetic parameters. (1973) (71)
Kinetics and mechanisms of the acid degradation of the aldopentoses to furfural. (1969) (68)
Prediction of stability of drugs and pharmaceutical preparations. (1962) (64)
Kinetics of Solvolyses of Various N-Alkyl-N-nitrosoureas in Neutral and Alkaline Solutions (1965) (64)
The Acid-Catalyzed Solvolysis of Pyrimidine Nucleosides1 (1966) (61)
Stability of Oil-in-Water Emulsions (1965) (61)
Pharmacokinetics of morphine and its surrogates. III: Morphine and morphine 3-monoglucuronide pharmacokinetics in the dog as a function of dose. (1979) (60)
Separation and spectrofluorometric assay of the -adrenergic blocker sotalol from blood and urine. (1971) (59)
The Bateman function revisited: A critical reevaluation of the quantitative expressions to characterize concentrations in the one compartment body model as a function of time with first-order invasion and first-order elimination (1994) (57)
Prediction of stability in pharmaceutical preparations. VIII. Oil-in-water emulsion stability and the analytical ultracentrifuge. (1962) (56)
Prediction of stability in pharmaceutical preparations XX: stability evaluation and bioanalysis of cocaine and benzoylecgonine by high-performance liquid chromatography. (1983) (56)
Solvolyses of cytosine and cytidine. (1972) (55)
Pharmacokinetics of Δ9-Tetrahydrocannabinol in Dogs (1977) (54)
Evaluation, control, and prediction of drug diffusion through polymeric membranes. 3. Diffusion of barbiturates, phenylalkylamines, dextromethorphan, progesterone, and other drugs. (1968) (52)
Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol. (1974) (51)
Kinetics of hydrolysis of barbituric acid derivatives. (1971) (50)
Kinetics and mechanisms of drug action of microorganisms XXIII: microbial kinetic assay for fluorouracil in biological fluids and its application to human pharmacokinetics. (1977) (48)
Pharmacokinetics of the -adrenergic blocker sotalol in dogs. (1973) (43)
Pharmacokinetics of morphine and its surrogates VI: Bioanalysis, solvolysis kinetics, solubility, pK'a values, and protein binding of buprenorphine. (1985) (41)
Pharmacokinetics of morphine and its surrogates. X: Analyses and pharmacokinetics of buprenorphine in dogs. (1990) (41)
Potentiometric Titrations of a Polydicarboxylic Acid: Maleic Acid-Styrene Copolymer (1951) (40)
Prediction of stability in pharmaceutical preparations. II. Vitamin stability in liquid multivitamin preparations. (1956) (40)
KINETICS AND MECHANISMS OF ACTION OF ANTIBIOTICS ON MICROORGANISMS. 3. INHIBITORY ACTION OF TETRACYCLINE AND CHLORAMPHENICOL ON ESCHERICHIA COLI ESTABLISHED BY TOTAL AND VIABLE COUNTS. (1965) (40)
KINETICS AND MECHANISMS OF ACTION OF ANTIBIOTICS ON MICROORGANISMS. I. REPRODUCIBILITY OF ESCHERICHIA COLI GROWTH CURVES AND DEPENDENCE UPON TETRACYCLINE CONCENTRATION. (1964) (39)
Kinetics and mechanisms of action of antibiotics on microorganisms. V. Chloramphenicol and tetracycline affected Escherichia coli generation rates. (1966) (38)
Picogram analysis of tetrahydrocannabinol and application to biological fluids. (1973) (36)
Prediction of stability in pharmaceutical preparations. I. Color stability in a liquid multisulfa preparation. (1955) (36)
Gas chromatographic analysis of trichloroethanol, chloral hydrate, trichloroacetic acid, and trichloroethanol glucuronide. (1966) (36)
High performance liquid chromatographic assays of the illicit designer drug "Ecstasy", a modified amphetamine, with applications to stability, partitioning and plasma protein binding. (1991) (35)
Kinetics and mechanisms of action of drugs on microorganisms. VII. Quantitative adherence of sulfonamide action on microbial growth to a receptor-site model. (1967) (35)
Stability of tetrahydrocannabinols. I. (1974) (34)
Electrochemical chromatographic determinations of morphine antagonists in biological fluids, with applications. (1984) (33)
Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs. (1985) (33)
Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans (1976) (32)
Kinetics and mechanisms of hydrolysis of 5-halouracils. (1968) (32)
Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability. (1977) (32)
Prediction of stability in pharmaceutical preparations. V. The solution degradation of the antibiotic streptovaricin. (1960) (32)
Alkaline transformations among glucose, fructose, and mannose (1970) (31)
High-performance liquid chromatographic assay of methadone, phencyclidine, and metabolites by postcolumn ion-pair extraction and on-line fluorescent detection of the counterion with applications. (1983) (31)
Kinetics and mechanisms of lactonization of coumarinic acids and hydrolysis of coumarins. I. (1971) (31)
Application of ion-pair methods to drug extraction from biological fluids. II. Quantitative determination of biguanides in biological fluids and comparison of protein binding estimates. (1972) (30)
Application of ion-pair methods to drug extraction from biological fluids. I. Quantitative determination of biguanides in urine. (1972) (30)
Metal complexes of thiouracils. I. Stability constants by potentiometric titration studies and structures of complexes. (1970) (30)
Kinetics and mechanisms of drug action on microorganisms. XVII. Bactericidal effects of penicillin, kanamycin, and rifampin with and without organism pretreatment with bacteriostatic chloramphenicol, tetracycline, and novobiocin. (1973) (29)
THE PHYSICAL CHEMICAL CHARACTERIZATION OF THE PRODUCTS, EQUILIBRIA, AND KINETICS OF THE COMPLEX TRANSFORMATIONS OF THE ANTIBIOTIC PORFIROMYCIN. (1963) (29)
Further Characterization of Neomycin B and Neomycin C (1955) (28)
Pharmacokinetics of β-Methyldigoxin in Healthy Humans I: Intravenous Studies (1977) (28)
Kinetics of antimicrobial action. (1978) (28)
Psicofuranine: kinetics and mechanisms in vivo with the application of the analog computer. (1960) (28)
Kinetics of the Hydrolytic Degradation of a Nucleoside, the Antibiotic Psicofuranine (1960) (27)
Kinetics and mechanisms of monolayer interactions. I. Cetyl sulfate and cetrimonium ions interacting with dipalmitoyl lecithin and dipalmitoyl glycerol. (1972) (26)
Quantification and prediction of the biological activities of chloramphenicol analogs by microbial kinetics. (1966) (26)
Prediction of stability in pharmaceutical preparations. XVI. Kinetics of hydrolysis of canrenone and lactonization of canrenoic acid. (1971) (26)
Pharmacokinetics and bioavailabilities of hymecromone in human volunteers (1993) (25)
Pharmacodynamics of the antiarrhythmic disopyramide in healthy humans: Correlation of the kinetics of the drug and its effects (1976) (24)
Kinetics and Mechanisms of Drug Action on Microorganisms (1969) (24)
Pharmacokinetics of morphine and its surrogates II: methods of separation of stabilized heroin and its metabolites from hydrolyzing biological fluids and applications to protein binding and red blood cell partition studies. (1979) (23)
Pharmacokinetics of morphine and its surrogates V: Naltrexone and naltrexone conjugate pharmacokinetics in the dog as a function of dose. (1985) (23)
VARIATION OF PKA'-VALUES OF TETRACYCLINES IN DIMETHYLFORMAMIDE-WATER SOLVENTS. (1963) (23)
THE ACTION OF TETRACYCLINE AND CHLORAMPHENICOL ALONE AND IN ADMIXTURE ON THE GROWTH OF ESCHERICHIA COLI * (1963) (22)
Drug Action and Assay by Microbial Kinetics (1971) (22)
Kinetics and mechanisms of action of drugs on microorganisms. 8. Quantification and prediction of the biological activities of meta- and para-substituted N1-phenylsulfanilamides by microbial kinetics. (1969) (22)
Pharmacokinetics of morphine and its surrogates I: comparisons of sensitive assays of morphine in biological fluids and application to morphine pharmacokinetics in the dog. (1978) (21)
Pharmacokinetics of morphine and its surrogates IV: Pharmacokinetics of heroin and its derived metabolites in dogs. (1980) (21)
THE SOLVOLYSIS OF 21-HYDROCORTISONE ESTERS AND HEMIESTERS. (1962) (21)
Prediction of stability in pharmaceutical preparations. XV. Kinetics of hydrolysis of 5-trifluoromethyl-2'-deoxyuridine. (1968) (21)
Prediction of stability in pharmaceutical preparations. X. Alkaline hydrolysis of hydrocortisone hemisuccinate. (1962) (20)
The Acidic Solvolytic Transformations of an Iodinated Nucleoside, the Antivitral 5-Iodo-2′-deoxyuridine (1964) (20)
KINETICS OF SOLVOLYSES OF VARIOUS N-ALKYL-N-NITROSOUREAS IN NEUTRAL AND ALKALINE SOLUTIONS. (1973) (20)
Surgically affected sulfisoxazole pharmacokinetics in the morbidly obese. (1981) (20)
5-methyl-3(2H)-furanone from acid-catalyzed solvolysis of 2-deoxy-D-ribose. (1967) (20)
PREDICTION OF STABILITY IN PAHRMACEUTICAL PREPARATIONS. 13. STABILITY, SPECTROPHOTOMETRIC , AND BIOLOGICAL ASSAY OF THE ANTIBIOTIC PORFIROMYCIN IN PHARMACEUTICALLY USEFUL PH RANGES. (1964) (19)
Kinetics of steroid effects on Ca-47 dynamics in dogs with the analog computer. II. (1962) (19)
Analog computer in drug dosage and formulation design. (1966) (19)
Separation and analysis of delta 9-tetrahydrocannabinol in biological fluids by high-pressure liquid chromatography and GLC. (1977) (19)
Studies on the stability of fumagillin. III. Thermal degradation in the presence and absence of air. (1954) (18)
Kinetics and mechanisms of lactonization of coumarinic acids and hydrolysis of coumarins. II. (1971) (18)
A basic model for the evaluation and prediction of preservative action (1966) (18)
SPECTROPHOTOMETRIC ANALYSES OF 2-DEOXY-D-RIBOSE IN PRESENCE OF NUCLEOSIDES. (1965) (18)
Preparation and Reactions of Steroidal Δ17,(20)-Enol Acetates (1954) (17)
Drug Fate and Metabolism: Methods and Techniques (1979) (17)
Kinetics and mechanisms of action of drugs on microorganisms. XI. Effect of erythromycin and its supposed antagonism with lincomycin on the microbial growth of Escherichia coli. (1970) (16)
Pharmacokinetics of beta-methyldigoxin in healthy humans III: Pharmacodynamic correlations. (1977) (16)
Studies on the stability of fumagillin. I. Photolytic degradation in alcohol solution. (1954) (16)
The Kinetics of 20-Keto Reduction in 11α-Acetoxypregnane-3,20-dione by Sodium Borohydride (1953) (16)
Kinetics and mechanisms of monolayer interactions. II. Effect of chain length of alkyl ionic surfactants on their interaction with dipalmitoyl glycerol, dipalmitoyl phosphatidylethanolamine, and dipalmitoyl lecithin. (1973) (15)
Studies on the stability of filipon. I. Thermal degradation in the presence of air. (1960) (15)
Prediction of Stability in Pharmaceutical Preparations XIX: Stability Evaluation and Bioanalysis of Clofibric Acid Esters by High-Pressure Liquid Chromatography (1982) (15)
Spectrophotometric Investigations of Organic Complexes from Copolymerization Monomers: the Instantaneous Complex Formation of Parasubstituted Styrenes and Maleic Anhydride1 (1953) (15)
Nonlinear pharmacokinetics of the new positive inotropic agent sulmazole in the dog. (1983) (14)
The Solvolysis of Aspirin Anhydride (1960) (14)
Kinetics and mechanisms of drug action on microorganisms. XX. Integrated receptor site model rationalizing observed microbial rate dependencies on drug concentration and microbial kinetics affected by sodium fusidate. (1974) (13)
Pharmacokinetics of papaverine hydrochloride and the biopharmaceutics of its oral dosage forms. (1978) (13)
Evidence for General Base Catalysis in an Ester Hydrolysis. II. Hydrolysis of an Aminoalkyl Acetylsalicylate1 (1958) (13)
Kinetics and mechanisms of monolayer interactions IV: Surface activity of alkanols and energies of their interaction with dipalmitoyllecithin and dipalmitoylphosphatidylethanolamine. (1977) (13)
Studies on the Stability of Furnagillin: II. Photolytic Degradation of Crystalline Furnagillin (1954) (13)
Pharmacokinetics of delta9-tetrahydrocannabinol in dogs. (1977) (13)
Prediction of stability in pharmaceutical preparations XVIII: application of high-pressure liquid chromatographic assays to study of nafronyl stability and bioanalysis. (1981) (13)
Plasmolysis, red blood cell partitioning, and plasma protein binding of etofibrate, clofibrate, and their degradation products. (1983) (12)
Solvolysis of adenine nucleosides. II. Effects of sugars and adenine substituents on alkaline solvolyses. (1972) (12)
The Neutral Solvolysis of the Aspirin Anion in Aqueous and Mixed Solvents (1961) (12)
PREDICTION OF STABILITY IN PHARMACEUTICAL PREPARATIONS. XII. SOLVOLYSIS OF VARIOUS ALKYL SYDNONES. (1964) (12)
Bretylium pharmacokinetics and bioavailabilities in man with various doses and modes of administration. (1982) (12)
Sensitive direct spectrophotometric determination of fructose and sucrose after acid degradation. (1967) (12)
Prediction of stability in pharmaceutical preparations. XIV. The complete pH dependent solvolytic degradations of an iodinated nucleoside, the antiviral 5-iodo-2'-deoxyuridine. (1965) (12)
Basis of hydrogen ion binding curves deduced from differences in solution and solvent titrations. (1963) (12)
Prediction of stability in pharmaceutical preparations. XXI: The analysis and kinetics of hydrolysis of a cocaine degradation product, ecgonine methyl ester, plus the pharmacokinetics of cocaine in the dog. (1994) (11)
Prediction of stability in pharmaceutical preparations. III. Comparison of vitamin stabilities in different multivitamin preparations. (1956) (11)
Solvolysis of 5-halouridines and related nucleosides. (1968) (11)
Evidence for General Base Catalysis in an Ester Hydrolysis. I. Hydrolysis of an Alkyl Aminoacetylsalicylate1 (1957) (10)
The physicochemical and pharmacokinetic bases for the biopharmaceutical evaluation of drug biological availability in pharmaceutical formulations. (2009) (10)
Comparisons of detections, stabilities, and kinetics of degradation of hymecromone and its glucuronide and sulfate metabolites. (1994) (10)
CYCOLHEXIMIDE TRANSFORMATIONS. II. KINETICS AND STABILITY IN A PHARMACEUTICALLY USEFUL PH RANGE. (1965) (10)
Bioavailability of racemic ibuprofen and its lysinate from suppositories in rabbits. (1993) (10)
Pharmacokinetics of morphine and its surrogates. VIII: Naloxone and naloxone conjugate pharmacokinetics in dogs as a function of dose and as affected by simultaneously administered morphine. (1986) (10)
Kinetics and mechanisms of drug action on microorganisms. XIV. The action of fluorouracil, other uracils and derived nucleosides on the microbial kinetics of Escherichia coli. (1972) (10)
Microbial Kinetics and Dependencies of Individual and Combined Antibiotic Inhibitors of Protein Biosynthesis (1973) (10)
Studies on the stability of fumagillin. II. Photolytic degradation of crystalline fumagillin. (1954) (9)
The pharmacokinetic bases of biological response quantification in toxicology, pharmacology and pharmacodynamics. (1977) (9)
Simplified methods for the evaluation of the parameters of the time course of plasma concentration in the one-compartment body model with first-order invasion and first-order drug elimination including methods for ascertaining when such rate constants are equal (1993) (9)
Kinetics and mechanisms of action of drugs on microorganisms. XV. Effect of erythromycin on the action of lincomycin (Phase II) and the 7 (S)-chloro analogs of lincomycin against Escherichia coli. (1972) (9)
Pharmacokinetics and clearances related to renal processes. (1978) (9)
Kinetics and mechanisms of drug action on microorganisms. X. Action of spectinomycin on Escherichia coli by microbial kinetics. (1970) (9)
The optimum use of acid preservatives in oil-water systems: benzoic acid in peanut oil-water. (1953) (9)
Prediction of stability in pharmaceutical preparations. IX. Solution degradation and chemical assay of the antibiotic actinospectacin. (1962) (9)
Kinetics and mechanisms of drug action on microorganisms. 13. Comparative studies on action of lincomycin, clindamycin, and U 24729A against Escherichia coli. (1972) (9)
Kinetics and mechanisms of action of drugs on microorganisms. XVI. Effect of oleandomycin and its combinations with tetracycline, chloramphenicol, erythromycin, lincomycin, and 1'-demethyl-4'-depropyl-4'-(R and S)-n-pentylclindamycin on microbial generation of Escherichia coli. (1973) (8)
Properties, stability, assay, and preliminary pharmacokinetics of the immunomodulatory 1,2-O-isopropylidene-3-O-3'(N',N'-dimethylamino-n-propyl)-D-glucofuranose hydrochloride. (1982) (8)
Kinetics and mechanisms of drug action on microorganisms. XXI. Effect of quinacrine on Escherichia coli and its possible complexation with components of nutrient growth medium. (1974) (8)
Pharmacokinetics and disposition of delta 9-tetrahydrocannabinol and its metabolites. (1978) (8)
Pharmacokinetics of saturably metabolized amobarbital (1974) (8)
Research ArticlesKinetics of Steroid Effects on Ca47 Dynamics in Dogs with the Analog Computer I (1962) (8)
The Kinetics of Hydrolysis of Scopolamine Derivatives with an Unusual Elimination on Alkaline Hydrolysis1 (1957) (7)
Prediction of stability in pharmaceutical preparations. VI. Stability, products, and mechanism in the pyrolytic degradation of aspirin anhydride. (1959) (7)
THE APPLICATION OF ANALOG COMPUTERS TO PROBLEMS OF PHARMACOKINETICS AND DRUG DOSAGE. (1964) (7)
Metal complexes of thiouracils. II. Solubility analyses and spectrophotometric investigations. (1971) (7)
Prediction of stability in pharmaceutical preparations. IV. The interdependence of solubility and rate in saturated solutions of acylsalicylates. (1957) (7)
The physical chemical evidence for aspirin anhydride as a superior form for the oral administration of aspirin. (1959) (7)
Pharmacokinetics of beta-methyldigoxin in healthy humans IV: comparisons of radioimmunoassays, total radioactivity, and specific assays of beta-methyldigoxin and digoxin in plasma. (1977) (6)
DETERMINATION OF THE HALF LIFE OF METAHEXAMIDE IN NORMAL HUMANS (1959) (6)
Spectrophotometric analysis of glucose and mixtures of glucose, fructose, and sucrose. (1969) (6)
Kinetics and mechanisms of drug action on microorganisms XXII: Effects of aminosidine with and without organism pretreatment with bacteriostatic agents. (1975) (6)
Pharmacokinetics of morphine and its surrogates. IX: Discrepancies among infused buprenorphine plasma concentrations sampled from different veins. (1989) (6)
Alkaline Hydrolysis of Scopolamine Methyl Bromide and Other Esters of Quaternary Amino Alcohols1 (1955) (6)
Metal complexes of thiouracils 3: polarographic studies and correlations among complex stabilities, thiouracil structures, and biological activities. (1972) (6)
Selection, evaluation, and control of the assay of the pharmaceutical product. I. Reproducibilities of assay and drug recovery from dosage forms. (1962) (5)
Prediction of stability in pharmaceutical preparations. XVII. Design of a nonprecipitating injectable potassium canrenoate solution. (1972) (5)
Correction of prior estimate of the biological activity of an N-trifluoroacetyl analogue of D-threo-chloramphenicol relative to chloramphenicol. (1977) (5)
Selection, evaluation, and control of the assay of the pharmaceutical product. V. Importance of assay validity, a case in point. (1962) (5)
Pharmacokinetics of intravenous and oral 1,2-O-isopropylidene-3-O-3'-(N',N'-dimethylamino-n-propyl)-D-glucofuranose hydrochloride in the dog as a function of dose and characterization of metabolites. (1983) (5)
Spectrophotometric analysis of ribose and 2-deoxy-D-ribose alone and in mixtures. (1967) (5)
Cycloheximide transformations. I. Kinetics and mechanisms in aqueous acid. (1966) (5)
QUANTIFICATION OF NORMAL AND ADRENAL STEROID AFFECTED CALCIUM METABOLISM IN THE YOUNG DOG. (1964) (4)
Acid and enzymic hydrolysis of N-butylformamide and its oral inefficacy. (1962) (4)
Kinetics and mechanisms of solvolysis of 5-iodocytosine. (1974) (4)
Stability of tetrahydrocannabinols II. (1978) (4)
Pharmacokinetics of morphine and its surrogates XI: Effect of simultaneously administered naltrexone and morphine on the pharmacokinetics and pharmacodynamics of each in the dog (1990) (4)
Treatment of refractory ventricular arrhythmias. High dose parenteral and oral bretylium tosylate. (1982) (4)
Effect of Novobiocin and Its Combination with Tetracycline, Chloramphenicol, Erythromycin, and Lincomycin on the Microbial Generation of Escherichia coli (1973) (4)
Bioanalyses and pharmacokinetics of nafronyl in the dog. (1984) (4)
Prediction and Evaluation of Emulsion Stability with Ultracentrifugal Stress (1970) (3)
Is it Possible to Teach Scientific Creativity in the Pharmaceutical Sciences? Anecdotes and Memorabilia (1985) (3)
Kinetic Studies on the Catalytic Hydrogenation of Isoergosterone (1956) (3)
Selection, Evaluation, and Control of the Assay of the Pharmaceutical Product II: Effect of Sampling and Bulk Mix Heterogeneity on Tablet Variation (1962) (3)
Selection, evaluation, and control of the assay of the pharmaceutical product. IV. Screening bulk drug stability and defining the assay of choice. (1962) (3)
Classification and evaluation of combined antibiotic activity. (1958) (3)
Kinetics and mechanisms in stability of drugs. (1967) (3)
Integral Procedures in Pharmacokinetics and their Application to the Parameter Determination of Appearing Metabolites (1984) (3)
Kinetics and mechanisms of drug action on microorganisms. IX. Inhibitory action of lincomycin on Escherichia coli by microbial kinetics. (1969) (3)
Classical pharmacokinetics to the frontier (1973) (3)
Polarography of various N-alkyl-N-nitrosoureas. (1966) (3)
PHARMACOKINETICS AND DISPOSITION OF Δ9-TETRAHYDROCANNABINOL AND ITS METABOLITES (1979) (3)
Basic Concepts and Experimental Methods of Pharmacokinetics (1970) (3)
Prediction of stability in pharmaceutical preparations. XI. Increased stability of soluble steroid hemiesters by steric hindrance. (1962) (2)
Analysis and Comparison of Ultraviolet Spectrophotometric Curves of Steroids with Application of the Analog Computer. (1962) (2)
STRUCTURE-ACTIVITY RELATIONSHIP OF CHLORAMPHENICOLS (1973) (2)
Facile acid hydrolysis of p-chlorobenzaldoxime and its oral inefficacy (1962) (2)
Pharmacokinetics of beta-methyldigoxin in healthy humans I: intravenous studies. (1977) (2)
Kinetics and mechanisms of monolayer interactions. III: models to explain time-dependent effects of injected cetrimonium bromide. (1975) (2)
Drug systems affecting availability and reliability of response. (1969) (2)
Determination of cycloheximide and its degradiation products alone and in mixtures. (1965) (2)
304 – PHARMACOKINETICS OF β-METHYLDIGOXIN IN HEALTHY HUMANS (1977) (2)
Gas liquid chromatography and high pressure liquid chromatography analyses of cannabinoids in biological fluids and applications (1979) (2)
GLC and HPLC Analyses of Cannabinoids in Biological Fluids and Applications (1979) (2)
The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs. (1970) (2)
Pharmacokinetics of the immunomodulatory 1,2-O-isopropylidene-3-O-3′-(N′,N′-dimethyl-amino-n-propyl)-D-glucofuranose hydrochloride in normal human volunteers (1982) (2)
Solvolysis of Symmetrical and Mixed Aspirin Anhydrides in 75% Dioxane–25% Water (1962) (1)
Scientific EditionPrediction of stability in pharmaceutical preparations V. *: The Solution Degradation of the Antibiotic Streptovaricin (1959) (1)
Psicofuranine: Correlation of Assay Methods in Acid Degradation Studies * (1960) (1)
Speech and Language Therapy Under an Automated Stimulus Control System. (1968) (1)
Predictions of stability in pharmaceutical preparations XIX: Stability evaluation and bioanalysis of clofibric acid esters by high-pressure liquid chromatography. (1982) (1)
Automatic sequence and photo control system for simultaneous ultracentrifugation in the analytical ultracentrifuge. (1967) (1)
FC33 dose-dependent first-order elimination of racemic ibuprofen in rabbits (1994) (0)
[Utilization of analog computers in the development of dosage forms]. (1971) (0)
Comment on Aspirin Bioavailability Monitoring (1981) (0)
Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogs. (1985) (0)
Solvolysis of symmetrical and mixed aspirin anhydrides in 17 per cent dioxane-25 per cent water. (1962) (0)
Index rerum vol. 14 (1969) (0)
Index autorum vol. 14 (1969) (0)
CORRECTION OF FUNCTIONAL MISARTICULATION UNDER AN AUTOMATED SELF-CORRECTION SYSTEM. FINAL REPORT. (1965) (0)
Kinetics of plasma coagulation and lysis I: Basic kinetic model for time course of coagulation-lysis systems and its potential application to clinical studies. (1978) (0)
Proceedings: Interpretation of pharmacokinetic results. (1974) (0)
Pharmacokinetics and their clinical significance. (1969) (0)
Statistical evaluation of the paper-disc plate method for neomycin assay. (1955) (0)
Chapter 27. Pharmaceutics, Pharmacokinetics and Biopharmaceutics (1969) (0)
DISCRIMINATION AND ARTICULATION PATTERNS AS MEASURED BY THE TEMPLIN SHORT TEST OF SOUND DISCRIMINATION AND THE TEMPLIN (2007) (0)
Erratum to: Simplified methods for the evaluation of the parameters of the time course of plasma concentration in the one-compartment body model with first-order invasion and first-order drug elimination including methods for ascertaining when such rate constants are equal (2006) (0)
Characterization and mode of degradation of the neurophysiologically important transaminase inhibitors, the alpha-aminooxyalkanoic acids. (1962) (0)
Decisions and the future (1988) (0)
Pharmacokinetic and Pharmacological Interactions of Antibacterial Drugs (1976) (0)
Chapter 32. Pharmaceutics, Pharmacokinetics and Biopharmaceutics (1968) (0)
Hgh Dose Parenferal and Oral Brefylium Tosylafe (2017) (0)
Theory and Use of Antibiotic Combinations: Part 1: Laboratory Aspects (1957) (0)
Contents, Vol. 14, 1969 (1969) (0)
Separation and sensitive assay of THC in biological fluids by HPLC and GLC. (1976) (0)
CORRECTION OF PRIOR ESTIMATE OF THE BIOLOGICAL ACTIVITY OF AN N-TRIFLUOROACETYL ANALOG OF D-THREO-CHLORAMPHENICOL RELATIVE TO CHLORAMPHENICOL (1977) (0)
[Pharmacokinetics of amobarbital]. (1975) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Edward R. Garrett?

Edward R. Garrett is affiliated with the following schools:

University of Florida

Edward R. Garrett's Academic­Influence.com Rankings

Why Is Edward R. Garrett Influential?

Edward R. Garrett's Published Works

Published Works

What Schools Are Affiliated With Edward R. Garrett?

Edward R. Garrett's AcademicInfluence.com Rankings